Professor at Oxford University. Head of Clinical Pharmacology, MORU, Thailand. Interested in pharmacokinetics-pharmacodynamics in Tropical Diseases.
Bangkok, Thailand
Joined March 2016
- Tweets81
- Following26
- Followers243
- Likes21
Joel Tarning retweeted
@Joel_Tarning @MORUBKK awarded @RSTMH 2025 Chalmers Medal
Joel has been honoured for his exceptional contribution to the field of clinical pharmacology of neglected tropical diseases, and in particular antimalarial therapy.
Read more 👉 tropicalmedicine.ox.ac.uk/ne…
Joel Tarning retweeted
#ResearchHighlight from @Joel_Tarning @MORUBKK
Dose-optimization of a novel co-formulated triple combination #antimalarial therapy: artemether-lumefantrine-amodiaquine
Read more 👉 ndm.ac/tropmed.res-hi
Full publication 👉 ascpt.onlinelibrary.wiley.co…
Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure pubmed.ncbi.nlm.nih.gov/3933…
Joel Tarning retweeted
Pharmacometric and statistical considerations for dose optimization doi.org/10.1002/psp4.13271
Joel Tarning retweeted
Congratulations to @Joel_Tarning, just named Distinguished International Fellow at #astmh2024. Joel was recognized for "his exceptional scholarly accomplishments [&] global leadership antimalarial pharmacology." Well done, Joel!
astmh.org/awards-fellowships…
Pharmacometric and statistical considerations for dose optimization doi.org/10.1002/psp4.13271
Joel Tarning retweeted
Attending #ASTMH2024? Be part of the Neglected Tropical Diseases symposium on Thursday 14th at 10 AM. The team will extensively discuss drug development, clinical trials, and #pharmacometrics when treating pregnant & breastfeeding women.
@ASTMH @GLIDE_AE @MORUBKK
@H3D_Foundation
Joel Tarning retweeted
In‐host modeling of dengue virus and non‐structural protein 1 and the effects of ivermectin in patients with acute dengue fever - Ding - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library ascpt.onlinelibrary.wiley.co…
Joel Tarning retweeted
New insights into #dengue! In-host dengue kinetic model quantitatively predicts dengue fever drug effects, offers valuable insights to inform dengue drug development and shows that #Ivermectin reduces NS1 but not viral load
Learn more! bit.ly/407X627
Photo @LukeDuggleby
In‐host modeling of dengue virus and non‐structural protein 1 and the effects of ivermectin in patients with acute dengue fever - Ding - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library ascpt.onlinelibrary.wiley.co…
Joel Tarning retweeted
Good news! No evidence of sub-optimal #malaria treatment or substantial changes in pharmacokinetic PK properties of ACT partner drugs amodiaquine & piperaquine during pregnancy.
Dose adjustment NOT warranted for women in 2nd/3rd trimester of pregnancy!
bit.ly/4dSvpy5
Joel Tarning retweeted
To avoid haemolysis in #G6PD deficient infants, treating breastfeeding mothers w/primaquine is not advised. But kids have <1% of mom's primaquine exposure, so significant haemolysis highly unlikely: Primaquine s/d not be restricted for breastfeeding women
go.nature.com/4c0Lyjx
Joel Tarning retweeted
Oxford’s research endeavour stretches beyond tropical medicine. Research across our full disciplinary power is coming together to tackle global health challenges ➡️ globalhealth.ox.ac.uk
Come chat to me or @JoMiller_Oxford to find out more #OTN2024
7/7
ALT Jo Miller and Leila Whitworth at Oxford Tropical Network Meeting 2024